Weight Loss
Menopause
menu-close
WHAT WE TREAT
Weight loss
icon
Menopause
icon
ACCOUNT
Log in
icon
OVERVIEW
Weight loss overview
icon
TREATMENTS
Explore all options
Explore all options
icon
Mounjaro
Mounjaro
Lose up to 23% body weight
icon
Wegovy
Wegovy
Lose up to 21% body weight
icon
Saxenda
Saxenda
Lose up to 10% body weight
icon
Orlos
Orlos
Lose up to 8% body weight
icon
PROGRAMME
How it works
How it works
icon
App
App
icon
ABOUT
Results
icon
Experts
icon
RESOURCES
Guides & tips
icon
ACCOUNT
Log in
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
OUR CLINIC
Menopause overview
icon
Pricing
icon
Specialists
icon
TREATMENT PLANS
Hormone replacement therapy
icon
Testosterone treatment
icon
Cognitive behavioural therapy
icon
Vaginal treatments
icon
BLOOD TESTS
Women's midlife (MOT) blood test
icon
Check your HRT and testosterone test
icon
Start testosterone blood test
icon
WHAT WE TREAT
Skincare
New
icon
Perimenopause
icon
Menopause
icon
ADHD and menopause
icon
Premenstrual Dysphoric Disorder (PMDD)
icon
LEARN
Guides
icon
Treatments
icon
ACCOUNT
Log in
icon
SUPPORT
FAQ
icon
Home/Guides & Tips/Weight loss/

Orforglipron side effects

Orforglipron side effects

Orforglipron is a new weight loss tablet that’s in clinical trials. Here’s what we know about the possible side effects.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 1st December 2025
Research-Based Guide
Table of contents
  • What is orforglipron and how d...
  • Common side effects
  • When do the side effects start...
  • Why do these side effects happ...
  • Less common side effects
  • Rare side effects of orforglip...
  • Can orforglipron cause pancrea...
  • How to manage orforglipron sid...
  • When to seek medical help
  • Your weight loss journey

Been wanting to try weight loss medication but not a fan of needles? We’ve got good news: there’s a few new weight loss tablets in development.

Orforglipron is one of them. And, like any medicine, it comes with side effects. Here’s what we know so far.

Key Takeaways

  • Orforglipron is a GLP-1 receptor agonist weight loss pill
  • Common side effects include digestive issues like diarrhoea and nausea, similar to other GLP-1 injections
  • Serious side effects like pancreatitis and gallbladder inflammation are rare
  • Most side effects occur when beginning treatment or when the dose increases, and often improve as the body adjusts
  • Orforglipron is expected to be available in 2026 at the earliest

What is orforglipron and how does it work?

Orforglipron is a weight loss pill that belongs to a family of medicines called GLP-1 receptor agonists.

If that sounds familiar, that’s because popular medicines like Wegovy and Mounjaro are also GLP-1 receptor agonists (technically, Mounjaro weight loss injections are GLP-1/GIP receptor agonists).

What that means is that these medicines work by mimicking the behaviour of GLP-1, a natural hunger hormone (Mounjaro also mimics the hormone GIP). This suppresses your appetite and keeps cravings at bay, so you eat less.

However, orforglipron is taken as a daily tablet rather than an injection.

Common side effects

In the ACHIEVE-1 clinical trial, the most commonly reported side effects of orforglipron were related to the gut:

  • Diarrhoea
  • Nausea
  • Indigestion
  • Constipation
  • Vomiting

Mostly, symptoms were mild to moderate. And they were comparable to the side effects of GLP-1 injections.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.

When do the side effects start and how long do they last?

Orforglipron side effects tend to come on when you first start the medicine or increase your dose. They are usually mild to moderate and often improve as your body adapts.

As with other GLP-1 medicines, you would start on a lower dose and increase gradually over time. This slow build up helps your body get used to the medicine and can reduce gut related side effects.

Why do these side effects happen?

It’s because of how orforglipron works. To make you feel full, orforglipron slows down your digestion and signals to the brain to curb your appetite. This helps you eat less—but it can also upset your gut.

Less common side effects

They’re less common, but these orforglipron pill side effects have also been reported:

  • Burping
  • Headache
  • Fatigue
  • Acid reflux
  • Dizziness

Rare side effects of orforglipron

There’s been reports of more serious side effects, but these are rare. Orforglipron has been associated with:

  • Acute cholecystitis (inflamed gallbladder)
  • Pancreatitis (inflammation of the pancreas)

These events were rare and the numbers are still small, so longer-term studies are needed to understand the true level of risk.

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

Can orforglipron cause pancreatitis?

Pancreatitis has occasionally been reported with GLP-1 medicines like Wegovy and Mounjaro, but it remains rare. A few mild cases have also appeared in early orforglipron studies, although numbers are very small.

Large real-world studies suggest GLP-1 medicines do not increase pancreatitis risk. In a major US analysis of over 160,000 people, pancreatitis rates were low and similar between GLP-1 users and non-users, and lifetime risk was actually lower in those taking GLP-1s.

It’s also important to remember that rapid weight loss can increase the risk of gallstones, which are a common trigger for pancreatitis. This means pancreatitis can occur during rapid weight loss from lifestyle changes alone, not just medication.

Overall, pancreatitis with orforglipron appears to be uncommon, but more clinical trial data are needed to understand the risk fully.

How to manage orforglipron side effects

Here’s some tips for easing orforglipron side effects:

  • Follow your provider’s dosing advice exactly. Taking a higher strength than prescribed, or moving up too quickly, can bring on side effects
  • Have more frequent, smaller meals, and eat them slowly. This can minimise the strain on your gut
  • Avoid spicy, greasy, or highly processed foods. They can irritate your stomach
  • Taking regular sips of cold water can help with nausea. It could also ease constipation and ensure you’re staying hydrated if you’ve been sick

When to seek medical help

Orforglipron isn’t approved yet, so a clinician can’t prescribe it to you.

But if it were available and you were taking it, it would be time to see a doctor if:

  • Your symptoms weren’t going away, were bothering you, or were getting worse
  • You had severe pain in your stomach, particularly if it spread to your back. This can be a sign of pancreatitis or an inflamed gallbladder
  • You had swelling in your face, lips, or tongue. These are signs of an allergic reaction. If that’s you, seek help right away

Your weight loss journey

We won’t see orforglipron on the market until 2026, at the earliest. But there are plenty of other weight loss medications out there that will help you reach your health goals. And you can get started on them right now.

At Voy, we’ve got Wegovy and Mounjaro, as well as orlistat weight loss pills. When you join our weight loss programme, we’ll post your medicine each month—and work with you to transform your lifestyle.

Ninety-four percent of our clients say it’s the best weight loss programme they’ve ever tried. Take our quiz to see if you’re eligible.

Don't wait to hit your health goals
Orforglipron isn’t available yet, but Wegovy and Mounjaro are already helping people lose weight. Start your journey today with proven treatments and support that sticks.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100k customers across the UK
FAQ

Orforglipron side effects: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Dutta, Deep, et al. “Orforglipron, a Novel Non‐peptide Oral Daily Glucagon‐like peptide‐1 Receptor Agonist as an Anti‐obesity Medicine: A Systematic Review and Meta‐analysis.” Obesity Science and Practicescribble-underline, vol. 10, no. 2, 2024:e743 https://pmc.ncbi.nlm.nih.gov/articles/PMC10896246/.

icon²

Eli Lilly. “Lilly's Oral GLP-1, Orforglipron, Demonstrated Statistically Significant Efficacy Results and a Safety Profile Consistent with Injectable GLP-1 Medicines in Successful Phase 3 trial,” Lilly.comscribble-underline, 2025 https://investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-demonstrated-statistically Accessed 14 Nov. 2025.

icon³

Gorgojo-Martínez, Juan J, et al. “Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus.” Journal of Clinical Medicinescribble-underline, vol. 12, no. 1, 2022:145 https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/.

icon⁴

Wharton, Sean, et al. “Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.” The New England Journal of Medicine,scribble-underline vol. 389, no. 10, 2023:877-888 https://www.nejm.org/doi/full/10.1056/NEJMoa2302392.

icon⁵

Wharton, Sean, et al. “Orforglipron, an Oral Small-molecule GLP-1 Receptor Agonist for Obesity Treatment,” The New England Journal of Medicinescribble-underline, vol. 393, 2025:1796-1806 https://www.nejm.org/doi/full/10.1056/NEJMoa2511774.

icon⁶

Wytiaz, Victoria, et al. “Foods Provoking and Alleviating Symptoms in Gastroparesis: Patient Experiences.” Digestive Diseases and Sciencesscribble-underline, vol. 60, 2015:1052-1058

icon⁷

https://link.springer.com/article/10.1007/s10620-015-3651-7.

icon⁸

https://pmc.ncbi.nlm.nih.gov/articles/PMC11818918/

icon⁹

https://www.nhs.uk/conditions/gallstones/

Take the first step towards weight loss that lasts.

card-image
Weight Loss
Orforglipron vs tirzepatide
Here’s how the new weight loss pill orforglipron compares to Mounjaro.
card-image
Weight Loss
Mazdutide vs tirzepatide: Which works better for weight loss?
We explore what’s known so far about mazdutide and how it might compare to approved treatments like Mounjaro
card-image
Weight loss
Do GLP-1s like Mounjaro cause muscle loss?
It’s natural to worry about muscle loss when taking weight-loss medications. Here’s what the research actually shows.
Have a question?
phone icon
020 3912 9885Monday - Friday 9am - 5pm
support icon
help@joinvoy.comWe aim to reply in 24hrs
email icon
press@joinvoy.comPress & media inquiries
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999.

Programme

  • How it works
  • Treatments
  • Coaching
  • The Voy App

Voy

  • Experts
  • Results

Legal

  • Privacy policy
  • Terms & Conditions
  • Terms of Sale
  • Complaints

Get help

  • Help Centre (FAQ)
facebooktwitterinstagram
Copyright 2025 Voy. All rights reserved.
Pharmacies: Manual PharmacySuperintendent Pharmacist: Vinisha KandaGPhC Registration: 2203475
registered pharmacycqc ratingcpd member